EcoDrugPlus

Si:dkey-211g8.6

Ensembl ID : ENSONIG00000043224
Gene Symbol: SI:DKEY-211G8.6
1 Cross references
320 Possible Orthologues:

Si:dkey-91m11.5

Ensembl ID : ENSONIG00000015935
Gene Symbol: SI:DKEY-91M11.5
1 Cross references
196 Possible Orthologues:

Sigma Non-Opioid Intracellular Receptor 1

Ensembl ID : ENSONIG00000004128
Gene Symbol: SIGMAR1
3 Cross references
204 Possible Orthologues:

Smoothened, Frizzled Class Receptor

Ensembl ID : ENSONIG00000011655
Gene Symbol: SMO
4 Cross references
204 Possible Orthologues:

Sodium Channel, Voltage Gated, Type V-Like, Alpha B

Ensembl ID : ENSONIG00000015515
Gene Symbol: SCN5LAB
1 Cross references
256 Possible Orthologues:

Sodium Channel, Voltage Gated, Type Xii, Alpha A

Ensembl ID : ENSONIG00000015630
Gene Symbol: SCN12AA
1 Cross references
248 Possible Orthologues:

Sodium Voltage-Gated Channel Alpha Subunit 4

Ensembl ID : ENSONIG00000009190
Gene Symbol: SCN4A
1 Cross references
191 Possible Orthologues:

Sodium Voltage-Gated Channel Alpha Subunit 8

Ensembl ID : ENSONIG00000011915
Gene Symbol: SCN8A
1 Cross references
215 Possible Orthologues:

Sodium- And Chloride-Dependent Gaba Transporter 1

Ensembl ID : ENSONIG00000017160
Gene Symbol: LOC100710201
4 Cross references
205 Possible Orthologues:

Sodium-Dependent Serotonin Transporter

Ensembl ID : ENSONIG00000007976
Gene Symbol: LOC100708943
3 Cross references
201 Possible Orthologues:

Sodium/glucose Cotransporter 1

Ensembl ID : ENSONIG00000003632
Gene Symbol: LOC100699559
3 Cross references
241 Possible Orthologues:

Sodium/hydrogen Exchanger 3

Ensembl ID : ENSONIG00000013756
Gene Symbol: LOC100692172
2 Cross references
223 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).